Jpmorgan Chase & CO Elanco Animal Health Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.12 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$707 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$658 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$313 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$286 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.37B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...